FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/10/016017 [Registered on: 15/10/2018] Trial Registered Prospectively
Last Modified On: 22/09/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Homeopathic Treatment of difficulty in moving shoulder joint 
Scientific Title of Study   A Double-blind, Randomized, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Individualized Homeopathic Medicines in Frozen Shoulder 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
U1111-1221-8323  UTN 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Debika Biswas 
Designation  Postgraduate Trainee 
Affiliation  Mahesh Bhattacharyya Homoeopathic Medical College and Hospital 
Address  Drainage Canal Road, Doomurjola, Howrah

Haora
WEST BENGAL
711104
India 
Phone  8017828168  
Fax    
Email  biswasdrdebika@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Shubhamoy Ghosh 
Designation  Professor and Head, Department of Pathology and Microbiology 
Affiliation  Mahesh Bhattacharyya Homoeopathic Medical College and Hospital 
Address  Drainage Canal Road, Doomurjola, Howrah 711104

Haora
WEST BENGAL
Shubhamoy Ghosh
India 
Phone  8240773920  
Fax    
Email  shubhamoy67@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Shubhamoy Ghosh 
Designation  Professor and Head, Department of Pathology and Microbiology 
Affiliation  Mahesh Bhattacharyya Homoeopathic Medical College and Hospital 
Address  Drainage Canal Road, Doomurjola, Howrah 711104


WEST BENGAL
Shubhamoy Ghosh
India 
Phone  8240773920  
Fax    
Email  shubhamoy67@gmail.com  
 
Source of Monetary or Material Support  
Mahesh Bhattacharyya Homoeopathic Medical College and Hospital; Drainage Canal Road, Doomurjola, Howrah - 711104; West Bengal; India 
 
Primary Sponsor  
Name  Mahesh Bhattacharyya Homoeopathic Medical College and Hospital 
Address  Drainage Canal Road, Doomurjola, Howrah 711104 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Debika Biswas  Mahesh Bhattacharyya Homoeopathic Medical College & Hospital  OPD room no 4, Dept of Surgery, Drainage Canal Road, Doomurjola, Howrah 711104
Haora
WEST BENGAL 
8017828168

biswasdrdebika@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M750||Adhesive capsulitis of shoulder,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized homeopathic medicines in centesimal potencies  Intervention is planned as administering indicated homeopathic remedies in centesimal potencies. Each dose consists of 4-6 cane sugar globules moistened with the indicated medicine (preserved in 90% v/v ethanol), to be taken orally on clean tongue with empty stomach; dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Along with medicines, the intervention arm will receive joint mobility exercise and reassurance. Duration of therapy: 3 months. 
Comparator Agent  Placebo  This group will receive indistinguishable placebo. Each dose consists of 4-6 cane sugar globules moistened with 90% v/v ethanol, to be taken orally on clean tongue with empty stomach; dosage and repetition depending upon the individual requirement of the cases. Along with placebo, this arm will receive joint mobility exercise and reassurance. Duration of therapy: 3 months. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  a) Cases suffering from frozen shoulder (ICD M75.02) for at least 3 months
b) Age 18-65 yrs
c) Both sexes
d) Patient having on ongoing standard or other alternative therapy for frozen shoulder, discontinued for at least 1 month
e) Literate patients; ability to read English and/or Bengali and capability and willingness to give informed consent and to comply with the study procedure 
 
ExclusionCriteria 
Details  a) Cases too sick for consultation
b) Cases unwilling to stay after the doctor’s visit
c) Patients unable to read patient information sheet
d) Patients unwilling to take part or not giving consent to join the study
e) Cases willing for or requiring immediate surgical intervention or undergoing major shoulder surgery in last 6 months
f) Diagnosed cases of uncontrolled systemic diseases, unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure
g) Patient with psychiatric disorders
h) Undergoing homoeopathic treatment for chronic disease within last 6 months
i) Self-reported immune-compromised state
j) Substance abuse and/or dependence
k) Pregnant and lactating women 
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Oxford Shoulder Score (OSS) measuring intensity of pain and related quality of life  At baseline, every month up to 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Shoulder Pain and Disability Index (SPADI) measures pain and disability  At baseline, every month up to 3 months 
 
Target Sample Size   Total Sample Size="128"
Sample Size from India="128" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/11/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Other (Terminated) 
Publication Details   None yet; to be published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
Frozen shoulder is a painful, often prolonged condition that is commonly managed in the primary care setting and requires careful clinical diagnosis and management. Despite over a hundred years of treating frozen shoulder, the definition, diagnosis, pathology and most efficacious treatments are still unclear. Systemic reviews of current treatments for frozen shoulder examine the evidence base behind physiotherapy, both oral and intra-articular steroid, hydro-dilatation, manipulation under anaesthesia and arthroscopic capsular release. Frozen shoulder is a self-limiting condition, lasting on average 2-3 years, and some study shows 20-50% of sufferers continue to have pain and restricted movement beyond 3 years. The precise prevalence is unknown, thus 2-5% found in general population. Homeopathy treatment for the said condition is claimed to be beneficial, still systematic research evidences remain compromised. In this prospective, double blind, randomised, placebo controlled, parallel arm trial aimed to evaluate the efficacy of individualised homeopathic treatment against placebo in treatment of frozen shoulder at Mahesh Bhattacharyya Homoeopathic Medical College and Hospital, 128 patients will be randomised in 1:1 ratio into either individualised homeopathic medicines or identical placebo. Oxford Shoulder Score (OSS) and Shoulder Pain and Disability Index (SPADI) will be used as the primary and secondary outcome measures respectively, measured at baseline, and every month up to 3 months. Comparative analysis will be carried out to detect group differences, if any. Results will be published in scientific journals.
 
Close